SPONSOR
Cancer Research UK
Total Trials
4
Recruiting
4
Phases
Phase 2, Phase 3, Phase 1, Phase 2
Conditions studied: Haematological MalignancyMalignancyMalignant NeoplasmLymphoproliferative DisordersNeoplasms by Histologic TypeNeoplasms by SiteCancerBrain NeoplasmsMelanomaGlioma
NCT05770544 Phase 2, Phase 3
Recruiting
DETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Paediatric and Teenage/Young Adult Patients With ROS1 Gene Fusion-Positive Cancers.
Haematological Malignancy
NCT06988475 Phase 2, Phase 3
Recruiting
DETERMINE Trial Treatment Arm 06: Capmatinib in Adult Patients With Cancers Harbouring MET Dysregulations
Solid Tumour
NCT05768178 Phase 2, Phase 3
Recruiting
DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers.
Haematological Malignancy
NCT06380816 Phase 1, Phase 2
Recruiting
A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer
Advanced Solid Tumours